Filing Details

Accession Number:
0001127602-21-027120
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-15 16:03:33
Reporting Period:
2021-10-13
Accepted Time:
2021-10-15 16:03:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1035440 Paul Sagan C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-13 2,250 $314.90 14,951 No 4 S Indirect By: Erwin Park LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By: Erwin Park LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 76,452 Indirect By: The Chatham Trust
Common Stock 370,407 Indirect By: The Paul Sagan Revocable Trust
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2021.
  2. Erwin Park LLC is an estate planning vehicle for the Reporting Person's family. The Chatham Trust is an irrevocable family trust for which the Reporting Person serves as a trustee. The Paul Sagan Revocable Trust is a revocable trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.